|
|
||||||||
Yale UniversityVA Positron Emission Tomography Center, Section of Cardiology, VA Healthcare System, New Haven; Divisions of Nuclear Medicine and Cardiovascular Medicine, Departments of Diagnostic Radiology and Medicine, Yale University School of Medicine, New Haven, Connecticut
Correspondence: For correspondence or reprints contact: Chin K. Ng, PhD, VA Healthcare System, Positron Imaging Center (115A), 950 Campbell Ave., West Haven, CT 06516.
ABSTRACT
This study was performed to evaluate the effect of insulin on myocardial kinetics of 18F-fluorodeoxyglucose (FDG) and glucose in patients with ischemic heart disease. Methods: Twelve male patients (age range 5479 yr; mean age 69 ± 8 yr) were studied during the fasting awake state. Patients with diabetes and previous myocardial infarction of the left anterior descending vascular bed were excluded from the study. Patients were injected with a 185-MBq (5-mCi) bolus of FDG during arterial and coronary sinus catheterization. Thirty minutes after FDG injection, paired basal arterial and coronary sinus blood samples were taken for the measurement of FDG and glucose uptake. Thereafter, a primed (100 mU · min1 · min2 for 10 min) continuous (50 mU · min2 · min1 infusion of insulin was administered for 60 min using the euglycemic clamp technique, and blood samples were repeated. Blood samples also were taken periodically for the measurement of arterial free fatty acids and insulin. Results: Euglycemic insulin infusion lowered arterial concentrations of free fatty acids, reducing myocardial extraction of free fatty acids by 85% and stimulated uptake of glucose and FDG. Myocardial glucose and FDG extraction fractions (%) increased from 1 ± 1 and 2 ± 2 at baseline to 8 ± 2 and 10 ± 3 during insulin infusion, respectively. The lumped constant value was estimated to be 1.44 ± 0.14 (r = 0.87)for the fasted state, 0.99 ± 0.07 (r = 0.74) during insulin infusion and 1.00 ± 0.05 (r = 0.92) when both groups of data were pooled together. Conclusion: The data obtained in this study show that FDG uptake quantitatively traces glucose uptake during physiological hyperinsulinemia in patients with ischemic heart disease.
Key Words: fluorine-18-fluorodeoxyglucose insulin lumped constant tracer kinetics
This article has been cited by other articles:
![]() |
R. Lautamaki, R. Borra, P. Iozzo, M. Komu, T. Lehtimaki, M. Salmi, S. Jalkanen, K. E. J. Airaksinen, J. Knuuti, R. Parkkola, et al. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E282 - E290. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lautamaki, K.E. J. Airaksinen, M. Seppanen, J. Toikka, M. Luotolahti, E. Ball, R. Borra, R. Harkonen, P. Iozzo, M. Stewart, et al. Rosiglitazone Improves Myocardial Glucose Uptake in Patients With Type 2 Diabetes and Coronary Artery Disease: A 16-Week Randomized, Double-Blind, Placebo-Controlled Study Diabetes, September 1, 2005; 54(9): 2787 - 2794. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Monti, C. Landoni, E. Setola, E. Galluccio, P. Lucotti, E. P. Sandoli, A. Origgi, G. Lucignani, P. Piatti, and F. Fazio Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1225 - H1231. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-X. He, R.-F. Shi, Y.-J. Wu, Y.-Q. Tian, X.-J. Liu, S.-W. Wang, R. Shen, X.-W. Qin, R.-L. Gao, J. Narula, et al. Direct Imaging of Exercise-Induced Myocardial Ischemia With Fluorine-18-Labeled Deoxyglucose and Tc-99m-Sestamibi in Coronary Artery Disease Circulation, September 9, 2003; 108(10): 1208 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Iozzo, P. Chareonthaitawee, D. Dutka, D. J. Betteridge, E. Ferrannini, and P. G. Camici Independent Association of Type 2 Diabetes and Coronary Artery Disease With Myocardial Insulin Resistance Diabetes, October 1, 2002; 51(10): 3020 - 3024. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Pappas, E. W. Olcott, and J. E. Drace Imaging of skeletal muscle function using 18FDG PET: force production, activation, and metabolism J Appl Physiol, January 1, 2001; 90(1): 329 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Utriainen, S. Lovisatti, S. Makimattila, A. Bertoldo, S. Weintraub, R. DeFronzo, C. Cobelli, and H. Yki-Jarvinen Direct measurement of the lumped constant for 2-deoxy-[1-14C]glucose in vivo in human skeletal muscle Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E228 - E233. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Otani, Y. Kagaya, Y. Yamane, M. Chida, K. Ito, S. Namiuchi, N. Shiba, Y. Koseki, M. Ninomiya, J. Ikeda, et al. Long-Term Right Ventricular Volume Overload Increases Myocardial Fluorodeoxyglucose Uptake in the Interventricular Septum in Patients With Atrial Septal Defect Circulation, April 11, 2000; 101(14): 1686 - 1692. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. McNulty Comparison of local and systemic effects of insulin on myocardial glucose extraction in ischemic heart disease Am J Physiol Heart Circ Physiol, March 1, 2000; 278(3): H741 - H747. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F. Kofoed, H. Schoder, R. J. Knight, and D. B. Buxton Glucose metabolism in reperfused myocardium measured by [2-18F] 2-fluorodeoxyglucose and PET Cardiovasc Res, January 14, 2000; 45(2): 321 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Laine, C. Katoh, M. Luotolahti, H. Yki-Jarvinen, I. Kantola, A. Jula, T. O. Takala, U. Ruotsalainen, H. Iida, M. Haaparanta, et al. Myocardial Oxygen Consumption Is Unchanged but Efficiency Is Reduced in Patients With Essential Hypertension and Left Ventricular Hypertrophy Circulation, December 14, 1999; 100(24): 2425 - 2430. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jadvar, H. W. Strauss, and G. M. Segall SPECT and PET in the Evaluation of Coronary Artery Disease RadioGraphics, July 1, 1999; 19(4): 915 - 926. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |